These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 10852622)
1. Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids. Krenger W; Rossi S; Holländer GA Transplantation; 2000 May; 69(10):2190-3. PubMed ID: 10852622 [TBL] [Abstract][Full Text] [Related]
2. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells. Krenger W; Rossi S; Piali L; Holländer GA Blood; 2000 Jul; 96(1):347-54. PubMed ID: 10891472 [TBL] [Abstract][Full Text] [Related]
3. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease. Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of I-Ad-, but not Db-restricted peptide-induced thymic apoptosis by glucocorticoid receptor antagonist RU486 in T cell receptor transgenic mice. Xue Y; Murdjeva M; Okret S; McConkey D; Kiuossis D; Jondal M Eur J Immunol; 1996 Feb; 26(2):428-34. PubMed ID: 8617314 [TBL] [Abstract][Full Text] [Related]
5. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery. Tian L; Lu L; Yuan Z; Lamb JR; Tam PK Transplantation; 2004 Jan; 77(2):183-9. PubMed ID: 14742978 [TBL] [Abstract][Full Text] [Related]
6. Characterization of thymic atrophy and the mechanism of thymocyte depletion after in vivo exposure to a mixture of herbicides. de la Rosa P; Barnett JB; Schafer R J Toxicol Environ Health A; 2005 Jan; 68(2):81-98. PubMed ID: 15762548 [TBL] [Abstract][Full Text] [Related]
8. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. Roggero E; Pérez AR; Tamae-Kakazu M; Piazzon I; Nepomnaschy I; Besedovsky HO; Bottasso OA; del Rey A J Endocrinol; 2006 Aug; 190(2):495-503. PubMed ID: 16899582 [TBL] [Abstract][Full Text] [Related]
9. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells. Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids delay age-associated thymic involution through directly affecting the thymocytes. Pazirandeh A; Jondal M; Okret S Endocrinology; 2004 May; 145(5):2392-401. PubMed ID: 14736739 [TBL] [Abstract][Full Text] [Related]
11. Interferon-γ- and glucocorticoid-mediated pathways synergize to enhance death of CD4(+) CD8(+) thymocytes during Salmonella enterica serovar Typhimurium infection. Deobagkar-Lele M; Chacko SK; Victor ES; Kadthur JC; Nandi D Immunology; 2013 Apr; 138(4):307-21. PubMed ID: 23186527 [TBL] [Abstract][Full Text] [Related]
12. During acute graft versus host disease CD28 deletion in donor CD8 Uri A; Lühder F; Kerkau T; Beyersdorf N Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878 [TBL] [Abstract][Full Text] [Related]
13. Conditional expression of a glucocorticoid receptor transgene in thymocytes reveals a role for thymic-derived glucocorticoids in thymopoiesis in vivo. Pazirandeh A; Jondal M; Okret S Endocrinology; 2005 Jun; 146(6):2501-7. PubMed ID: 15731366 [TBL] [Abstract][Full Text] [Related]
14. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice. Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186 [TBL] [Abstract][Full Text] [Related]
15. Thymic atrophy caused by ethanol in a mouse model for binge drinking: involvement of endogenous glucocorticoids. Han YC; Lin TL; Pruett SB Toxicol Appl Pharmacol; 1993 Nov; 123(1):16-25. PubMed ID: 8236255 [TBL] [Abstract][Full Text] [Related]
16. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease. Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884 [TBL] [Abstract][Full Text] [Related]
17. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease. Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of graft-versus-host disease by double-negative regulatory T cells. Young KJ; DuTemple B; Phillips MJ; Zhang L J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991 [TBL] [Abstract][Full Text] [Related]
19. Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients. Chau LA; Rohekar S; Wang JJ; Lian D; Chakrabarti S; Zhang L; Zhong R; Madrenas J Clin Exp Immunol; 2002 Jan; 127(1):43-52. PubMed ID: 11882031 [TBL] [Abstract][Full Text] [Related]
20. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas. Fu Y; Paul RD; Wang Y; Lopez DM J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]